(Q42668179)

4 November 2017

title

Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E. (English)

1 reference

4 November 2017

Damon B Bowe

1

1 reference

4 November 2017

Nicholas J Kenney

series ordinal

2

1 reference

4 November 2017

Yair Adereth

series ordinal

3

1 reference

4 November 2017

Ioanna G Maroulakou

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

4 November 2017

1 reference

4 November 2017

volume

21

1 reference

4 November 2017

issue

2

1 reference

4 November 2017

page(s)

291-298

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205025

4 November 2017

exact match

0 references

cites work

Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Cyclin D1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

A new high frequency polymorphism in the HER-2/neu oncogene in normal tissue and breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Cyclin E, a redundant cyclin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Biological and clinical significance of HER2 overexpression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Inhibition of ras-induced proliferation and cellular transformation by p16INK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

inferred from DOI database lookup

7 January 2021

based on heuristic

Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1205025

1 reference

Dimensions Publication ID

4 November 2017

1016175008

0 references

1 reference